Myasthenia gravis during the course of neuromyelitis optica

Case Reports in Neurology

Volumn 3, Issue 3, 2011, Pages 268-273

  Etemadifar, Masoud ^a,b,c   Abtahi, Seyed Hossein ^a,b,c   Dehghani, Alireza ^a,d   Abtahi, Mohammad Ali ^a,d   Akbari, Mojtaba ^a   Tabrizi, Nasim ^a   Goodarzi, Tannaz ^e,f,g  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan Medical Students Research Committee (IMSRC)   (Iran)

^c Isfahan Research Committee of Multiple Sclerosis   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e National institute of genetic Engineering and Biotechnology   (Iran)

^f Department of Plant Biotechnology   (Iran)

^g SHA Official Research Center of Neurological Ophthalmological Sciences (SHARNOS Co)   (Iran)

Author keywords

Aquaporin 4; Devic's syndrome; Interferon; Multiple sclerosis; Myasthenia gravis; Neuromyelitis optica; Thymectomy

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; EDROPHONIUM CHLORIDE; INTERFERON BETA SERINE; MITOXANTRONE; PREDNISOLONE; PROTEIN ANTIBODY; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; CASE REPORT; CORTICOSTEROID THERAPY; DIPLOPIA; DISEASE COURSE; FATIGUE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LOW DRUG DOSE; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; NERVE STIMULATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; OPTIC NEURITIS; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; PTOSIS; SPASTIC PARAPLEGIA; SPINE RADIOGRAPHY;

EID: 84855760363     PISSN: None     EISSN: 1662680X     Source Type: Journal    
DOI: 10.1159/000334128     Document Type: Article

References (22)

1. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007;130:1224-1234. (Pubitemid 47355951)
2. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S: 'Cloud-like enhancement' is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66:425-428.
3. Uzawa A, Mori M, Arai K, Sato Y, Hayakawa S, Masuda S, et al: Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010;16:1443-1452.
4. Thornton IL, Rizzo JF, Cestari DM: Neuromyelitis optica: a review. Semin Ophthalmol 2011;26:337-341.
5. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG: Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
6. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al: A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-2112. (Pubitemid 39626806)
7. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al: Pathogenic potential of Ig G binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007;69:2221-2231. (Pubitemid 350294677)
8. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al: Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008;65:78-83.
9. Mc Keon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, et al: Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 2009;39:87-90.
10. Vincent A, Palace J, Hilton-Jones D: Myasthenia gravis. Lancet 2001;30:357:2122-2128. (Pubitemid 32607461)
11. Uzawa A, Mori M, Iwai Y, Kobayashi M, Hayakawa S, Kawaguchi N, et al: Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J Neurol Sci 2009;15:287:105-107.
12. Kohsaka M, Tanaka M, Tahara M, Araki Y, Mori S, Konishi T: A case of subacute myelitis with anti-aquaporin 4 antibody after thymectomy for myasthenia gravis: review of autoimmune diseases after thymectomy. Rinsho shinkeigaku 2010;50:111-113.
13. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489. (Pubitemid 43958540)
14. Kister I, Gulati S, Boz C, Bergamaschi R, Piccolo G, Oger J, et al: Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006;63:851-856. (Pubitemid 43882293)
15. Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D, et al: Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 1999;103:865-872. (Pubitemid 29297590)
16. Kay CS, Scola RH, Lorenzoni PJ, Jarius S, Arruda WO, Werneck LC: NMO-Ig G positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 2008;15;275:148-150.
17. Furukawa Y, Yoshikawa H, Yachie A, Yamada M: Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol 2006;13:655-658. (Pubitemid 43873639)
18. Dionisiotis J, Zoukos Y, Thomaides T: Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment. J Neurol Neurosurg Psychiatry 2004;75:1079. (Pubitemid 38869639)
19. Speciale L, Saresella M, Caputo D, Ruzzante S, Mancuso R, Calvo MG, et al: Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol 2000;6(suppl 2):S57-S61. (Pubitemid 30348913)
20. Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, et al: Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 1999;1:162:74-83. (Pubitemid 29064122)
21. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, et al: Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256-259. (Pubitemid 46592781)
22. Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi D, et al: Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 2010;291:37-43.